ImageneBio, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $35.00K, a 22.22% decline year-over-year.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $45.00K.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $15.00K, a 37.50% decline year-over-year.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $121.00K, a 78.96% decline year-over-year.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $45.00K.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $136.00K, a 87.58% decline from fiscal 2022.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.09M, a 88.14% increase from fiscal 2021.
- ImageneBio, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $582.00K, a 731.43% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $35.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $45.00K 10-K · filed 2026-03-10 | |
| 2025-03-31 | $45.00K 10-Q · filed 2026-08-05 | |
| 2023-12-31 | $136.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $121.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $1.09M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $24.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $575.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $495.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $582.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $69.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $35.00K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $242.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $70.00K 10-K · filed 2022-03-17 | |
| 2020-03-31 | $21.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |